RegMed XB collaborates on ambitious projects in the field of regenerative medicine. The partners in the collaboration are health foundations, universities, regional governments, and companies. In Phase 1, four health foundations (Nierstichting, Diabetes Fonds, Diabetes Onderzoek Nederland, and Reumafonds) join to define the research objectives and co-govern the project to keep a focus on the end-goals that improve patients' lives. Scientists from four universities (Leiden University, Utrecht University/Hubrecht Institute, Eindhoven University of Technology, and Maastricht University) join to bring in and further develop their proven technology and expertise that can be applied to challenges set by the health foundations. Companies join to share expertise and facilities, provide materials and personnel, and work as valorization instruments. And finally, four regions (Leiden, Utrecht, Noord-Brabant, and Limburg) join to support both the research and its valorization, thereby creating new jobs and businesses. RegMed XB is expected to expand to include partners in Flanders and other health foundations.